Evidence map›Paper›PMID 33513732›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Injectable Glycol Chitosan Hydrogel Containing Folic Acid-Functionalized Cyclodextrin-Paclitaxel Complex for Breast Cancer Therapy.

Hoon Hyun, Min Ho Park, Gayoung Jo, Bo Young Lee, Jae Won Choi, Heung Jae Chun, Hyeon Soo Kim, Dae Hyeok Yang

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Applications of Hydrogels in Emergency Therapy.Gels (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Application of mPEG-CS-cRGD/Drug delivery · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hoon HyunDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju 61469, Korea.ORCID 0000-0002-9106-6755
Min Ho ParkDepartment of Surgery, Chonnam National University Medical School, Gwangju 61469, Korea.
Gayoung JoDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju 61469, Korea.
Bo Young LeeDepartment of Biomedical Sciences, Chonnam National University Medical School, Gwangju 61469, Korea.
Jae Won ChoiLumenbio Co., LTD., Seoul 08590, Korea.
Heung Jae ChunDepartment of Biomedical & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0002-0446-9901
Hyeon Soo KimInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Dae Hyeok YangInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.ORCID 0000-0001-9853-8332
Chonnam National University · KRCatholic University of Korea · KR

Funding

Ministry of SMEs and Startups S2782460Ministry of Trade, Industry & Energy 20003560 and 20004627
6 · The paper itself

Abstract

We prepared a drug carrier which consisted of injectable methacrylated glycol chitosan (MGC) hydrogel, and a conjugate of 6-monodeoxy-6-monoamino-β-cyclodextrin⋅hydrochloride (6-NH

Indexed as

beta-cyclodextrinbreast cancer therapyfolic acidglycol chitosanpolyethylene glycol

Identifiers

PMID33513732
PMCPMC7910883
OpenAlexW3125514793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.